Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 5
Submit an article Journal homepage
5,104
Views
5
CrossRef citations to date
0
Altmetric
HPV – Research Paper

Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years

Ivette Maldonadoa Department of Obstetrics & Gynaecology, Fundación Santa Fe de Bogotá, Bogotá, ColombiaView further author information
,
Manuel Platab Department of Gynaecology, Fundación Cardioinfantil, Bogotá, ColombiaView further author information
,
Mauricio Gonzalezc Ginecologo Oncologo, Instituto Nacional de Cancerología, Bogotá, ColombiaView further author information
,
Alfonso Corread Clínica del Country, Bogotá, ColombiaView further author information
,
Claudia Nossae Cafam, Bogotá, ColombiaView further author information
,
Anna R. Giulianof Center for Immunization and Infection Research in Cancer, Moffitt Cancer Center and Research Institute, Tampa, FL, USAORCID Iconhttps://orcid.org/0000-0002-5440-8859View further author information
ORCID Icon,
Elmar A. Jourag Department of Obstetrics & Gynaecology, Medical University of Vienna, Vienna, AustriaORCID Iconhttps://orcid.org/0000-0003-0885-1013View further author information
ORCID Icon,
Alex Ferenczyh Department of Gynecologic Pathology and Cytopathology, University Health Center and Jewish General Hospital, Montreal, Quebec, CanadaView further author information
,
Brigitte M. Ronnetti Johns Hopkins Gynecologic Pathology Consultation Service, The Johns Hopkins University School of Medicine, Baltimore, MD, USAView further author information
,
Mark H. Stolerj Department of Pathology, University of Virginia Health System, Charlottesville, VA, USAView further author information
,
Hao Jin Zhouk Merck & Co., Inc, Rahway, NJ, USAView further author information
,
Amita Joshik Merck & Co., Inc, Rahway, NJ, USAView further author information
,
Rituparna Dask Merck & Co., Inc, Rahway, NJ, USAView further author information
,
Oliver Bautistak Merck & Co., Inc, Rahway, NJ, USAView further author information
,
Thomas Groupk Merck & Co., Inc, Rahway, NJ, USAView further author information
,
Alain Luxembourgk Merck & Co., Inc, Rahway, NJ, USAView further author information
,
Alfred Saahk Merck & Co., Inc, Rahway, NJ, USAView further author information
&
Ulrike Kirsten Buchwaldk Merck & Co., Inc, Rahway, NJ, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6671-0115View further author information
ORCID Icon show all
Article: 2078626 | Received 02 Mar 2022, Accepted 13 May 2022, Published online: 19 Jul 2022

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.